Kardium Inc.
This study will evaluate the long-term safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal atrial fibrillation.
Key Inclusion Criteria: * A diagnosis of recurrent symptomatic paroxysmal atrial fibrillation * Failure or intolerance of at least one antiarrhythmic drug (AAD) Class I or III Key Exclusion Criteria: * Persistent or long-standing persistent atrial fibrillation (continuous atrial fibrillation that is sustained \>12 months) * Atrial fibrillation secondary to a reversible cause or of non-cardiac origin * History of thromboembolic events within the past six months * Myocardial infarction (MI)/percutaneous coronary intervention (PCI) within the last three months * Any cardiac surgery within the…
Ablation and atrial mapping with the Globe Pulsed Field System
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.